As a young man, I was privileged to be an eyewitness to the rise of the Christian spiritual formation movement. It began, in its modern form, in 1978, when Richard Foster wrote what has become the ...

Having secured one of last year’s largest funding rounds, AI-focused Formation Bio is now eyeing up 545 million euros ($626 million) in potential paydays from a licensing deal with Sanofi. The French ...

Founders: Benjamine Liu (CEO), Linhao Zhang Launched: 2016 Headquarters: New York City Funding: $600 million Valuation: $1.7 billion (PitchBook) Key Technologies: Artificial intelligence, deep neural ...

A seven-ship dissimilar formation with B-2A, B-1B, B-52H, F-22A, F-15C, F-16C and A-10C showcased the Air Force’s capabilities at the Air and Sea Show in Miami Beach. In a ceremonial flypast during ...

I recently read about a spiritual formation program that went terribly wrong. A cohort of men spent three years in intense formation learning about the way of Jesus. This wasn’t merely an academic ...

Astronomers have found evidence of a process that supports an alternative, more rapid approach to planetary formation, more top down than bottom up. By Katrina Miller When it comes to making a planet, ...

"Illegal formation, offense ... five-yard penalty, repeat the down." That sentence was heard a lot during the opening quarter of Thursday's NFL season opener between the Baltimore Ravens and Kansas ...

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.

Megarounds have been few and far between in 2024, but Formation Bio has managed to draw in an impressive $372 million series D as the AI-focused biotech seeks to expand its pipeline. AI companies like ...

Learn how to get Python up and running on Windows, macOS, or Linux—and avoid the biggest pitfalls along the way. Python is easy to use, friendly to the beginner, and powerful enough to create robust ...

May 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development ...